A Single-Arm Exploratory Study of NatureU Histra Dissolve on Chronic Urticaria Symptoms

This was a single-center, open-label, single-arm, exploratory self-controlled study evaluating NatureU Histra Disslove in adults with chronic urticaria symptoms. Twenty-four participants were screened, 19 participants were enrolled, and 19 participants completed the study and were included in the effectiveness analysis. Participants took one tablet of the study product orally once daily, 20 minutes before a main meal, for 28 consecutive days. Urticaria Control Test, Urticaria Activity Score 7, and Dermatology Life Quality Index assessments were performed at baseline, Day 14, and Day 28. Safety was monitored during the study.

NCT Number	NCT07611032
Lead Sponsor	OmniSolutions Laboratory Holdings Limited
Conditions	Chronic Urticaria, Urticaria, Angioedema
Enrollment	19 participants
Start Date	2024-10-04
Primary Completion	2024-11-01 (estimated)
Study Completion	2024-11-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-28